- Conditions
- Intraocular Retinoblastoma, Hearing Loss
- Interventions
- Distortion product otoacoustic emission measurement (DPOAE)
- Diagnostic Test
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 3 Months to 18 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2024
- U.S. locations
- 1
- States / cities
- New York, New York
Source: ClinicalTrials.gov public record
Updated Nov 6, 2024 · Synced May 21, 2026, 11:09 PM EDT